BRPI0814449A2 - Compostos e sais dos mesmos - Google Patents

Compostos e sais dos mesmos

Info

Publication number
BRPI0814449A2
BRPI0814449A2 BRPI0814449-4A BRPI0814449A BRPI0814449A2 BR PI0814449 A2 BRPI0814449 A2 BR PI0814449A2 BR PI0814449 A BRPI0814449 A BR PI0814449A BR PI0814449 A2 BRPI0814449 A2 BR PI0814449A2
Authority
BR
Brazil
Prior art keywords
formula
salts
compounds
ammonium
diammonium
Prior art date
Application number
BRPI0814449-4A
Other languages
English (en)
Inventor
Julien Leveque
Nicolas Barbarin
Magali Palacio
Original Assignee
Ucb Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Pharma Sa filed Critical Ucb Pharma Sa
Publication of BRPI0814449A2 publication Critical patent/BRPI0814449A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C329/00—Thiocarbonic acids; Halides, esters or anhydrides thereof
    • C07C329/12—Dithiocarbonic acids; Derivatives thereof
    • C07C329/14—Esters of dithiocarbonic acids
    • C07C329/16—Esters of dithiocarbonic acids having sulfur atoms of dithiocarbonic groups bound to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C333/00—Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C333/14—Dithiocarbamic acids; Derivatives thereof
    • C07C333/18—Esters of dithiocarbamic acids
    • C07C333/26—Esters of dithiocarbamic acids containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acyldithiocarbamates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0814449-4A 2007-08-03 2008-07-17 Compostos e sais dos mesmos BRPI0814449A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07015316 2007-08-03
EP07019390 2007-10-03
PCT/EP2008/059396 WO2009019119A1 (en) 2007-08-03 2008-07-17 Sulfanyl derivatives and their use as synthesis intermediates

Publications (1)

Publication Number Publication Date
BRPI0814449A2 true BRPI0814449A2 (pt) 2015-08-25

Family

ID=39708930

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0814449-4A BRPI0814449A2 (pt) 2007-08-03 2008-07-17 Compostos e sais dos mesmos

Country Status (15)

Country Link
US (1) US8084638B2 (pt)
EP (1) EP2173708B1 (pt)
JP (1) JP5264904B2 (pt)
KR (1) KR20100043220A (pt)
CN (1) CN101796023B (pt)
AT (1) ATE501117T1 (pt)
AU (1) AU2008285765B2 (pt)
BR (1) BRPI0814449A2 (pt)
CA (1) CA2695075A1 (pt)
DE (1) DE602008005459D1 (pt)
EA (1) EA016532B1 (pt)
MX (1) MX2010000826A (pt)
PL (1) PL2173708T3 (pt)
WO (1) WO2009019119A1 (pt)
ZA (1) ZA201000259B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017527618A (ja) * 2014-09-08 2017-09-21 ゴッサム バイオファーマシューティカルズ,インコーポレイティド 肺サルコイドーシスの治療方法
US10158458B2 (en) 2015-05-29 2018-12-18 Huawei Technologies Co., Ltd. Systems and methods for partial collision multiple access
AU2020224153B2 (en) * 2019-02-22 2025-03-06 Cila Therapeutic Inc. Inhalable therapeutic agent
EP4177245A1 (en) * 2020-07-10 2023-05-10 Adama Agan Ltd. Process and intermediates for the preparation of fenoxasulfone

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2695310A (en) * 1951-12-12 1954-11-23 Lever Brothers Ltd Preparation of guanidinium mercaptoalkanesulfonate
JPS59231064A (ja) * 1983-06-13 1984-12-25 Mitsui Toatsu Chem Inc 2−メルカプトエチルアミン類の製造法
JP2881033B2 (ja) * 1991-02-05 1999-04-12 三井化学株式会社 メルカプトアミン類の製造法
EP0934261B1 (en) * 1996-10-01 2001-10-31 Bionumerik Pharmaceuticals, Inc. Process for producing dithiobis-alkanesulfonates and phosphonates
FR2811987A1 (fr) * 2000-07-18 2002-01-25 Expansia Sa Procede de preparation du 2,2'-dithiobis(ethanesulfonate) de disodium
AU2004299131B2 (en) * 2003-12-17 2010-05-13 Bionumerik Pharmaceuticals, Inc. Process for synthesizing disulfides

Also Published As

Publication number Publication date
ZA201000259B (en) 2011-03-30
JP5264904B2 (ja) 2013-08-14
CA2695075A1 (en) 2009-02-12
US20100292505A1 (en) 2010-11-18
US8084638B2 (en) 2011-12-27
AU2008285765B2 (en) 2011-02-03
DE602008005459D1 (de) 2011-04-21
MX2010000826A (es) 2010-03-01
ATE501117T1 (de) 2011-03-15
JP2010535168A (ja) 2010-11-18
PL2173708T3 (pl) 2011-08-31
EA016532B1 (ru) 2012-05-30
CN101796023A (zh) 2010-08-04
KR20100043220A (ko) 2010-04-28
EA201000256A1 (ru) 2010-08-30
AU2008285765A1 (en) 2009-02-12
HK1141786A1 (en) 2010-11-19
EP2173708B1 (en) 2011-03-09
CN101796023B (zh) 2012-06-27
EP2173708A1 (en) 2010-04-14
WO2009019119A1 (en) 2009-02-12

Similar Documents

Publication Publication Date Title
CY1124882T1 (el) Αναλογα 1,4-διϋποκατεστημενης πυριδαζινης και μεθοδοι για την θεραπευτικη αγωγη καταστασεων συναφων με ανεπαρκεια smn
EA201101671A1 (ru) Замещенные производные аминопропионовой кислоты в качестве ингибиторов неприлизина
JO3067B1 (ar) بيرميدينات بيرازولو امينو كمثبطات ل fak
EA201201378A1 (ru) Определенные аминопиримидины, композиции на их основе и способы их использования
EA201390723A1 (ru) Аминозамещенные производные бисфенилпентановой кислоты в качестве ингибиторов nep
ATE542813T1 (de) 6-substituierte 2- heterocyclylaminopyrazinverbindungen als chk-1- inhibitoren
EA201200763A1 (ru) Замещенные производные карбамоилметиламиноуксусной кислоты в качестве новых ингибиторов nep
EA201000113A1 (ru) Пиразольные соединения
JO3142B1 (ar) طريقة تحضير 5-ثنائي فينيل -4-أمينو-2-ميثيل بينتانويك أسيد
EA201101672A1 (ru) Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина
EA201100503A1 (ru) Глюкозидные производные и их применения
PT2323972E (pt) Compostos de tetraciclina substituídos com c7-flúor
EA201290632A1 (ru) Производные бетулина
EA201691119A1 (ru) Производные мочевины или их фармакологически приемлемые соли
TN2011000400A1 (en) Inhibitors of beta-secretase
MX337516B (es) Derivados de 1,2,4-tiazolidin-3-ona y uso en el tratamiento del cancer.
EA201071329A1 (ru) Диамидные производные адамантана и их применение
EA201071019A1 (ru) Кристаллические формы производных фениламинопиримидина
ATE440833T1 (de) Antithrombotische diamide
EA201690072A1 (ru) Состав, содержащий гиполипидемическое средство
BRPI1013821A8 (pt) piridinas substituídas como antagonistas de ccr3.
CY1113240T1 (el) Αλατα ενωσεων αναστολεα hiv
EA200601963A1 (ru) Соли дигидрожасмоновой кислоты и их применение в сельском хозяйстве
JOP20250214A1 (ar) مشتقات هيدروكينازولين لعلاج مرض أو اضطراب
EA201000256A1 (ru) Сульфанилпроизводные и их применение в качестве промежуточных соединений для синтеза

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.